184 related articles for article (PubMed ID: 17076975)
1. Increasing importance of dry eye syndrome and the ideal artificial tear: consensus views from a roundtable discussion.
Asbell PA
Curr Med Res Opin; 2006 Nov; 22(11):2149-57. PubMed ID: 17076975
[TBL] [Abstract][Full Text] [Related]
2. Choice of artificial tear formulation for patients with dry eye: where do we start?
Tong L; Petznick A; Lee S; Tan J
Cornea; 2012 Nov; 31 Suppl 1():S32-6. PubMed ID: 23038032
[TBL] [Abstract][Full Text] [Related]
3. Relative costs of various preserved artificial tear solutions for the treatment of dry eye conditions.
Enzenauer RW; Kao A; Williams T; Lambert RW
Eye Contact Lens; 2003 Oct; 29(4):238-40. PubMed ID: 14555900
[TBL] [Abstract][Full Text] [Related]
4. Clinical performance of a mid-viscosity artificial tear for dry eye treatment.
Simmons PA; Vehige JG
Cornea; 2007 Apr; 26(3):294-302. PubMed ID: 17413956
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of an enhanced viscosity artificial tear for moderate to severe dry eye disease: A multicenter, double-masked, randomized 30-day study.
Lievens C; Berdy G; Douglass D; Montaquila S; Lin H; Simmons P; Carlisle-Wilcox C; Vehige J; Haque S
Cont Lens Anterior Eye; 2019 Aug; 42(4):443-449. PubMed ID: 30573298
[TBL] [Abstract][Full Text] [Related]
6. Antioxidant and inflammatory cytokine in tears of patients with dry eye syndrome treated with preservative-free versus preserved eye drops.
Jee D; Park SH; Kim MS; Kim EC
Invest Ophthalmol Vis Sci; 2014 Jul; 55(8):5081-9. PubMed ID: 24994869
[TBL] [Abstract][Full Text] [Related]
7. The correct diagnosis and therapeutic management of tear dysfunction: recommendations of the P.I.C.A.S.S.O. board.
Rolando M; Cantera E; Mencucci R; Rubino P; Aragona P
Int Ophthalmol; 2018 Apr; 38(2):875-895. PubMed ID: 28397148
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of using preservative-free artificial tears versus preserved lubricants for the treatment of dry eyes: a systematic review.
Ribeiro MVMR; Barbosa FT; Ribeiro LEF; Sousa-Rodrigues CF; Ribeiro EAN
Arq Bras Oftalmol; 2019 Sep; 82(5):436-445. PubMed ID: 31508669
[TBL] [Abstract][Full Text] [Related]
9. The Effect of Tear Supplementation with 0.15% Preservative-Free Zinc-Hyaluronate on Ocular Surface Sensations in Patients with Dry Eye.
Perényi K; Dienes L; Kornafeld A; Kovács B; Kiss HJ; Szepessy Z; Nagy ZZ; Barsi Á; Acosta MC; Gallar J; Kovács I
J Ocul Pharmacol Ther; 2017; 33(6):487-492. PubMed ID: 28375789
[TBL] [Abstract][Full Text] [Related]
10. Effect of changing from preserved prostaglandins to preservative-free tafluprost in patients with glaucoma on tear film thickness.
Hommer A; Schmidl D; Kromus M; Bata AM; Fondi K; Werkmeister RM; Baar C; Schmetterer L; Garhöfer G
Eur J Ophthalmol; 2018 Jul; 28(4):385-392. PubMed ID: 29592773
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of sodium hyaluronate and carboxymethylcellulose in treating mild to moderate dry eye disease.
Lee JH; Ahn HS; Kim EK; Kim TI
Cornea; 2011 Feb; 30(2):175-9. PubMed ID: 21045674
[TBL] [Abstract][Full Text] [Related]
12. [A new approach for better comprehension of diseases of the ocular surface].
Baudouin C
J Fr Ophtalmol; 2007 Mar; 30(3):239-46. PubMed ID: 17417148
[TBL] [Abstract][Full Text] [Related]
13. A Critical Appraisal of the Physicochemical Properties and Biological Effects of Artificial Tear Ingredients and Formulations.
Weng J; Fink MK; Sharma A
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769079
[TBL] [Abstract][Full Text] [Related]
14. Effect of artificial tears on visual performance in subjects with dry eye.
Ridder WH; Tomlinson A; Paugh J
Optom Vis Sci; 2005 Sep; 82(9):835-42. PubMed ID: 16189494
[TBL] [Abstract][Full Text] [Related]
15. Ocular allergy and dry eye syndrome.
Bielory L
Curr Opin Allergy Clin Immunol; 2004 Oct; 4(5):421-4. PubMed ID: 15349042
[TBL] [Abstract][Full Text] [Related]
16. Issues in the use of preservative-free topicals.
Perry HD; Donnenfeld ED
Manag Care; 2003 Dec; 12(12 Suppl):39-41. PubMed ID: 14723113
[TBL] [Abstract][Full Text] [Related]
17. Additive Effect of preservative-free sodium hyaluronate 0.1% in treatment of dry eye syndrome with diquafosol 3% eye drops.
Hwang HS; Sung YM; Lee WS; Kim EC
Cornea; 2014 Sep; 33(9):935-41. PubMed ID: 25055152
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of 0.3% carbomer gel compared to placebo in patients with moderate-to-severe dry eye syndrome.
Sullivan LJ; McCurrach F; Lee S; Taylor HR; Rolando M; Marechal-Courtois C; Creuzot-Garcher C; Easty DL; Karabatsas C; Bingh Hoh M; Faschinger C; Laroche L
Ophthalmology; 1997 Sep; 104(9):1402-8. PubMed ID: 9307633
[TBL] [Abstract][Full Text] [Related]
19. Comparison of treatment with preservative-free versus preserved sodium hyaluronate 0.1% and fluorometholone 0.1% eyedrops after cataract surgery in patients with preexisting dry-eye syndrome.
Jee D; Park M; Lee HJ; Kim MS; Kim EC
J Cataract Refract Surg; 2015 Apr; 41(4):756-63. PubMed ID: 25487027
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the clinical course of dry eye syndrome.
Horwath-Winter J; Berghold A; Schmut O; Floegel I; Solhdju V; Bodner E; Schwantzer G; Haller-Schober EM
Arch Ophthalmol; 2003 Oct; 121(10):1364-8. PubMed ID: 14557170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
